JOVIE DE LEON-LUCK: Open Payments
NPI 1992119960 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 12 payments from 7 companies in 2025. Trend: 2023 $592 · 2024 $899 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $141 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Lilly USA, LLC | 2 | $46 |
| PFIZER INC. | 1 | $20 |
Products named: Kerendia, AREXVY, BREZTRI, JARDIANCE, MOUNJARO, AIRSUPRA, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
